Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 50% decrease from the number of companies cited in the previous quarter.
The citations in the county include:
- The owner or operator of a repackager/relabeler did not submit the required device listing information for the establishment's device(s).
- Software validation activities and results for computers or automated data processing systems used as part of the quality system have not been adequately documented.
- Procedures have not been adequately established to control product that does not conform to specified requirements.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Globalmedia Group, LLC | Devices | 10/25/2024 | Devices not listed |
Globalmedia Group, LLC | Devices | 10/25/2024 | Documentation of software validation |
Globalmedia Group, LLC | Devices | 10/25/2024 | Nonconforming product, Lack of or inadequate procedures |
Globalmedia Group, LLC | Devices | 10/25/2024 | Documentation |
Globalmedia Group, LLC | Devices | 10/25/2024 | DMR device specifications |
Globalmedia Group, LLC | Devices | 10/25/2024 | Lack of or inadequate complaint procedures |